Lv3
296 积分 2023-12-06 加入
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
5小时前
待确认
673P Final analysis of a phase III study: Comparing cisplatin plus endostatin versus cisplatin plus placebo in patients with malignant pleural effusion or malignant ascites (COREMAP)
11天前
已完结
Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma
23天前
已完结
Low-dose chemotherapy remodels hepatic immune landscape and potentiates antitumor response to immune checkpoint blockade in cholangiocarcinoma
23天前
已完结
Subcutaneously administered anti-PD-(L)1 antibodies are predominantly absorbed via the lymphatic system, resulting in high drug exposure to draining lymph nodes
27天前
已完结
Envafolimab Inhibits the Growth of Gastric Cancer Cells with Low PD-L1 Expression through the DDX20/NF-κB/TNF-α Signaling Pathway
27天前
已完结
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
30天前
已完结
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
30天前
已完结
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
1个月前
已完结
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study
1个月前
已完结
皖公网安备34019202002308
